Enterprise Trust & Investment’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$5.63M Sell
23,143
-140
-0.6% -$34.3K 2.35% 8
2022
Q1
$5.63M Sell
23,283
-1,000
-4% -$230K 2.01% 10
2021
Q4
$5.46M Buy
24,283
+6,330
+35% +$1.34M 1.91% 10
2021
Q3
$3.82M Hold
17,953
1.54% 17
2021
Q2
$4.38M Hold
17,953
1.79% 14
2021
Q1
$4.47M Hold
17,953
2% 13
2020
Q4
$4.25M Sell
17,953
-50
-0.3% -$11.5K 2% 13
2020
Q3
$4.58M Hold
18,003
2.56% 8
2020
Q2
$4.25M Buy
18,003
+1,400
+8% +$319K 2.53% 8
2020
Q1
$3.37M Sell
16,603
-150
-0.9% -$32.8K 2.36% 12
2019
Q4
$4.04M Sell
16,753
-50
-0.3% -$11K 2.25% 11
2019
Q3
$3.25M Sell
16,803
-1,025
-6% -$197K 1.99% 15
2019
Q2
$3.29M Buy
+17,828
New +$3.19M 2.04% 16

Other funds holding AMGN

Enterprise Trust & Investment's AMGN Position: Q2 2022 in Review

Enterprise Trust & Investment reduced its Amgen (AMGN) stake by 0.6% in Q2 2022, selling an estimated $34.3K and leaving 23,143 shares worth $5.63M. The position accounts for 2.35% of the portfolio, ranked #8.

Enterprise Trust & Investment first reported a position in AMGN in Q2 2019 and has held it in 13 quarters since. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Enterprise Trust & Investment held 23,143 shares of Amgen worth $5.63M as of Q2 2022.
  • Enterprise Trust & Investment sold 140 Amgen shares in Q2 2022, an estimated $34.3K.
  • Amgen made up 2.35% of Enterprise Trust & Investment's portfolio in Q2 2022, its #8 holding.
  • Enterprise Trust & Investment first reported a position in Amgen in Q2 2019 and has held it in 13 quarters since.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.